Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Halaven (eribulin mesylate) for the Treatment of Advanced Liposarcoma

Drug (Brand / Generic)

Halaven (eribulin mesylate)

Company

Eisai

Therapy Class

Chemotherapy

Current Indication

Liposarcoma

Market Sector

Oncology

Development Status

Approved in the US
Expand

Go Top